Novo Nordisk A/S (NONOF) 은(는) 상장 기업입니다 헬스케어 섹터의 바이오 산업에서 운영. 본사 소재지는 Bagsvaerd, Denmark. 현재 CEO는 Maziar Mike Doustdar.
NONOF 을(를) 보유 IPO 날짜 2010-05-07, 77,406 명의 정규직 직원, 에 상장 Other OTC, 시가총액 $172.47B.
Novo Nordisk A/S is a global healthcare company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company operates through two primary segments: Diabetes and Obesity Care, which includes insulins, GLP-1 therapies, oral antidiabetic products, and obesity treatments; and Biopharmaceuticals, which focuses on haemophilia, growth disorders, and hormone replacement therapy. Founded in 1923 and headquartered in Bagsvaerd, Denmark, Novo Nordisk maintains strategic collaborations with industry partners including Gilead Sciences and Lumen Bioscience to advance its pipeline in cardiometabolic disease treatments.
